Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2023Clinical and Experimental MedicineOpen Access

Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLiyang LvUniversity of Science and Technology of ChinaXQXiaolong QiZhongda Hospital Southeast UniversityCWChun WangSinopec (China)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lv et al. (2023) studied this question.

synapsesocial.com/papers/6a7dfd4610b6f5f3737d9a9chttps://doi.org/10.1007/s10238-023-01018-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma2013 · 105 citations
  2. 2Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities2009 · 127 citations
  3. 3Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types2017 · 262 citations
  4. 4Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets2017 · 184 citations
  5. 5Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort2017 · 84 citations